Lessons learned from an injectable opioid agonist therapy (iOAT) program in British Columbia

A webinar in partnership with the Dr. Peter Centre.

Opioid agonist therapy (OAT) is a medical treatment option used to treat opioid dependency and to reduce the harms of illicit opioid use disorder. Injectable opioid agonist therapy (iOAT) provides medically supervised pharmaceutical grade opioids for injection.

In the summer of 2019, the Dr. Peter Centre launched an iOAT program within their integrated healthcare facility.

This webinar will engage senior management, clinicians and peers in a discussion around overcoming barriers to iOAT implementation, as well as lessons learned from program implementation.

Moderator: Amanda Giacomazzo, CATIE

Speakers:

Scott Elliott, Executive Director, Dr. Peter Centre
Rosalind Baltzer Turje, Senior Director of Clinical Programs, Dr. Peter Centre
Ora Sagmoen, Peer Liaison, Dr. Peter Centre

Lessons learned from an injectable opioid agonist therapy (iOAT) program in British Columbia

Stimulant use disorder: Practice update

Opioid agonist therapy: A synthesis of Canadian guidelines for treating opioid use disorder

Integrated care model for hepatitis C, HIV and substance use during the COVID-19 pandemic